| Net loss | -10.1M |
| Depreciation | 1.32M |
| Amortization | 983K |
| Loss on disposal of assets | 10K |
| Stock based compensation | 2.31M |
| Gain on sale of patent | |
| Interest on royalty obligation | |
| Fair value of contingent consideration | |
| Accounts receivable | 2.2M |
| Inventory | 596K |
| Prepaid expenses, other current assets and deposits | -504K |
| Accounts payable | -16K |
| Accrued salaries, warranty and other expenses | 309K |
| Deferred revenue | -2.58M |
| Net cash (used for) provided by operating activities | |
| Disposals (additions) to patents, technology and other | -12K |
| Additions to property and equipment | -337K |
| Proceeds from sale of patent | |
| Cash paid for acquisition of Xoft | 0 |
| Net cash (used for) provided by investing activities | |
| Taxes paid related to restricted stock issuance | -114K |
| Net cash used for financing activities | |
| Increase (decrease) in cash and equivalents | -6.7M |
| Cash and equivalents, beginning of period | 15.28M |
| Cash and equivalents, end of period | 8.59M |